EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS

被引：0
|
作者：
Meyer, S. [1 ]
Deuse, T. [2 ]
Baholli, L. [1 ]
Sattinger, E. [1 ]
Schlueter, M. [1 ]
von Stritzky, A. [1 ]
Reichenspurner, H. [2 ]
Costard-Jaeckle, A. [1 ]
机构：
[1] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Allgemeine & Intervent Kardiol, Hamburg, Germany
[2] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Herz & Gefasschirurg, Hamburg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [31] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
  • [32] Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimens
    Burker, Britta S.
    Gullestad, Lars
    Gude, Einar
    Authen, Anne Relbo
    Grov, Ingelin
    Hol, Per K.
    Andreassen, Arne K.
    Arora, Satish
    Dew, Mary Amanda
    Fiane, Arnt E.
    Haraldsen, Ira R.
    Malt, Ulrik F.
    Andersson, Stein
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [33] Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 Months' follow-up
    Rothenburger, Markus
    Teerling, Elisa
    Bruch, Christian
    Lehmkuhl, Hans
    Suwelack, Barbara
    Bara, Christoph
    Wichter, Thomas
    Hinder, Frank
    Schmid, Christof
    Stypmann, Joerg
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (03): : 250 - 257
  • [34] Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study
    Barten, Markus J.
    Hirt, Stephan W.
    Garbade, Jens
    Bara, Christoph
    Doesch, Andreas O.
    Knosalla, Christoph
    Grinninger, Carola
    Stypmann, Joerg
    Sieder, Christian
    Lehmkuhl, Hans B.
    Porstner, Martina
    Schulz, Uwe
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (11) : 3006 - 3017
  • [35] CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS IN COMBINATION WITH THE CALCINEURIN INHIBITOR TACROLIMUS OR CYCLOSPORIN A
    Fuchs, U.
    Zittermann, A.
    Sunavsky, J.
    Gaertner, O.
    Schulze, B.
    Ensminger, S.
    Schulz, U.
    Gummert, J.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 18 - 18
  • [36] Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
    Bergh, Niklas
    Gude, Einar
    Bartfay, Sven-Erik
    Andreassen, Arne
    Arora, Satish
    Dahlberg, Pia
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    Karasson, Kristjan
    Radegran, Goran
    Bollano, Entela
    Andersson, Bert
    ESC HEART FAILURE, 2020, 7 (02): : 567 - 576
  • [37] Predicting Adverse Events in Liver Transplant Patients on Everolimus-Based Immunosuppression
    De Simone, Paolo
    Carrai, Paola
    Coletti, Laura
    Precisi, Arianna
    Ghinolfi, Davide
    Filipponi, Franco
    TRANSPLANTATION, 2016, 100 : S227 - S227
  • [38] Ab initio Everolimus-Based vs. Standard CNI Immunosuppression-Regimen in Liver Transplant Recipients
    Manzia, Tommaso Maria
    Quaranta, Claudia
    Toti, Luca
    Sforza, Daniele
    Pellicciaro, Marco
    Vella, Ivan
    Tariciotti, Laura
    Tisone, Giuseppe
    TRANSPLANTATION, 2018, 102 : S384 - S384
  • [39] Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor
    Brandhorst, Gunnar
    Tenderich, Gero
    Zittermann, Armin
    Oezpeker, Cenk
    Koerfer, Reiner
    Oellerich, Michael
    Armstrong, Victor William
    THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 113 - 116
  • [40] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    TRANSPLANTATION, 2014, 98 : 804 - 805
12345